Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The prime driver for the market is the health awareness drives. This is leading to the smoke and ash less smoking. Advancement in technology has triggered the focus on the market. The change in lifestyle habits is driving the market. The product comes in different flavors and fragrances to meet differing demands. The ban on public smoking in some countries is a plus point for the market.
This product could be used anywhere and it is environment-friendly as well. Furthermore, e-cigarettes are more economical than cigarettes due to high taxation on cigarettes and their rising prices.
The major restraint on the market is the risk and side effects of using the product. Consumer acceptability could be an issue in the growth of the market. The opportunity for the market lies in the technological advancement and research and development.The growing demand and popularity of the product hold a major scope for the future of the market. Health concerns will drive smokers towards tobacco alternatives.
Market Segmentation
The market is segmented in terms of the distribution channel into online and retail. The market is divided into first-generation, second-generation and third-generation on the basis of the product. On the basis of size, the market is divided into generation resources, storage, and advanced controls.
Regional/Geographic Analysis
North America dominates the market. Europe comes next in the list with strong demand. Asia Pacific has the highest growth potential with rising awareness of the product.
Key Players
Some of the major players in the market include British American Tobacco, Japan Tobacco, Phillip Morris International, Njoy, Reynolds American, Altria Group, and Imperial Brands.
Report Contents:
> Global E-Cigarettes Market segments
> Global E-Cigarettes Market Drivers, Restraints and Opportunities
> Global E-Cigarettes Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Global E-Cigarettes Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>>US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Westren Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastren Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Global E-Cigarettes Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...